✦ LIBER ✦

Bevacizumab in advanced breast cancer: an opportunity as second-line therapy?

✍ Scribed by Petrelli, Fausto (author);Barni, Sandro (author)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in advanced breast cancer: a

✍ Petrelli, Fausto (author);Barni, Sandro (author) 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 239 KB

Adriamycin, vinblastine and mitomycin C

✍ Aaron Sulkes; Eliahu Gez; M. Raphael Pfeffer; Raphael Catane; Rut Isacson; Shosh 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 643 KB

A phase II trial of mitomycin C and 5-fl

✍ Mary E R O'Brien; E J Bayliss; Moira E Stewart; John F Smyth; Alan Rodger; R C F 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 195 KB

Irinotecan monotherapy as second-line tr

✍ Seong Yoon Yi; Young Suk Park; Hyo Song Kim; Hyun Jung Jun; Kyoung Ha Kim; Myung 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 218 KB

Biweekly administration of gemcitabine a

✍ Angelo Dinota; Domenico Bilancia; Rosangela Romano; Luigi Manzione 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 71 KB

Weekly low-dose mitoxantrone plus doxoru

✍ M. Bontenbal; A. S. Th. Planting; C. J. Rodenburg; A. Dees; J. Verweij; C. C. M. 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 459 KB